Actuate Therapeutics, Inc.
ACTU
$5.39
$0.081.41%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
1/21/2026
-
GuruFocus
1/21/2026
-
GuruFocus
1/21/2026
-
The Fly
1/21/2026
-
The Fly
1/21/2026
-
Globe Newswire
1/20/2026
-
Ticker Report
1/20/2026
-
Ticker Report
1/19/2026
-
MarketBeat
1/17/2026
-
MarketBeat
1/15/2026
-
TipRanks Financial Blog
1/12/2026
-
GuruFocus
1/12/2026
-
TipRanks Financial Blog
1/12/2026
-
The Fly
1/8/2026
-
MarketBeat
1/7/2026
-
MarketBeat
1/7/2026
-
Ticker Report
1/6/2026
-
GuruFocus
1/6/2026
-
GuruFocus
1/6/2026
-
Globe Newswire
12/31/2025
-
MarketBeat
12/24/2025
-
Zacks Investment Research
12/18/2025
-
GuruFocus
12/18/2025
-
Globe Newswire
12/15/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 13, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 9 and 13 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
817 887 8455
Address
1751 River Run
Fort Worth, TX 76107
Fort Worth, TX 76107
Country
Year Founded
Business Description
Sector
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company’s lead product candidate is elraglusib...
more